Polar Capital Holdings’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,582
Closed -$1.17M 272
2025
Q1
$1.17M Sell
5,582
-213,934
-97% -$41.6M 0.01% 268
2024
Q4
$39M Sell
219,516
-11,955
-5% -$2.2M 0.22% 114
2024
Q3
$45.7M Sell
231,471
-90,321
-28% -$16.9M 0.22% 93
2024
Q2
$55.2M Sell
321,792
-2,384
-0.7% -$395K 0.33% 76
2024
Q1
$59M Sell
324,176
-37,632
-10% -$6.49M 0.31% 79
2023
Q4
$56.1M Sell
361,808
-5,064
-1% -$738K 0.34% 84
2023
Q3
$54.7M Buy
366,872
+8,000
+2% +$1.17M 0.41% 72
2023
Q2
$48.4M Buy
358,872
+37,368
+12% +$5.48M 0.24% 87
2023
Q1
$51.2M Buy
321,504
+7,167
+2% +$1.1M 0.33% 82
2022
Q4
$50.8M Sell
314,337
-14,173
-4% -$2.17M 0.4% 83
2022
Q3
$44.1K Buy
328,510
+45,718
+16% +$6.56M 0.28% 83
2022
Q2
$43.3K Buy
282,792
+236,416
+510% +$36.1M 0.25% 85
2022
Q1
$7.52K Hold
46,376
0.03% 241
2021
Q4
$6.28K Hold
46,376
0.02% 251
2021
Q3
$5K Buy
46,376
+5,504
+13% +$629K 0.02% 278
2021
Q2
$4.6K Buy
+40,872
New +$4.6M 0.02% 284

Other funds holding ABBV

Polar Capital Holdings's ABBV Position: Q2 2025 in Review

Polar Capital Holdings sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 5,582 shares — an estimated $1.17M sold.

Polar Capital Holdings first reported a position in ABBV in Q2 2021 and held it in 16 quarters. The position peaked at $59M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Polar Capital Holdings reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 5,582 AbbVie shares in Q2 2025, an estimated $1.17M.
  • Polar Capital Holdings first reported a position in AbbVie in Q2 2021 and held it in 16 quarters.
  • Polar Capital Holdings's AbbVie position peaked at $59M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Polar Capital Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.